Effective Canadian policy to reduce harms from prescription opioids: learning from past failures.
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (Fischer, Rehm); Department of Psychiatry (Fischer, Rehm), University of Toronto; Institute of Medical Science, Faculty of Medicine (Fischer, Rehm), University of Toronto; Dalla Lana School of Public Health (Rehm), University of Toronto, Toronto, Ont.; Department of Medicine (Tyndall), Faculty of Medicine, The University of British Columbia; BC Centre for Disease Control (Tyndall), Vancouver, BC benedikt.fischer@camh.ca.
Benedikt
B
Fischer
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (Fischer, Rehm); Department of Psychiatry (Fischer, Rehm), University of Toronto; Institute of Medical Science, Faculty of Medicine (Fischer, Rehm), University of Toronto; Dalla Lana School of Public Health (Rehm), University of Toronto, Toronto, Ont.; Department of Medicine (Tyndall), Faculty of Medicine, The University of British Columbia; BC Centre for Disease Control (Tyndall), Vancouver, BC.
Jürgen
J
Rehm
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (Fischer, Rehm); Department of Psychiatry (Fischer, Rehm), University of Toronto; Institute of Medical Science, Faculty of Medicine (Fischer, Rehm), University of Toronto; Dalla Lana School of Public Health (Rehm), University of Toronto, Toronto, Ont.; Department of Medicine (Tyndall), Faculty of Medicine, The University of British Columbia; BC Centre for Disease Control (Tyndall), Vancouver, BC.
Mark
M
Tyndall
D000701:Analgesics, Opioid; D002170:Canada / Q000453:epidemiology; D062787:Drug Overdose / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy; D019317:Evidence-Based Medicine; D040261:Harm Reduction; D006291:Health Policy; D006801:Humans; D009293:Opioid-Related Disorders / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy
D000701:Analgesics, Opioid